194 related articles for article (PubMed ID: 34185313)
41. Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease.
Xia M; Yang X; Qian C
Am J Cardiol; 2021 Feb; 140():33-38. PubMed ID: 33137319
[TBL] [Abstract][Full Text] [Related]
42. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
43. Prophylactic anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
[TBL] [Abstract][Full Text] [Related]
44. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Holgersson J; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
PLoS One; 2021; 16(3):e0248132. PubMed ID: 33705495
[TBL] [Abstract][Full Text] [Related]
45. Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis.
Varshney AS; Wang DE; Bhatt AS; Blood A; Sharkawi MA; Siddiqi HK; Vaduganathan M; Monteleone PP; Patel MR; Jones WS; Lopes RD; Mehra MR; Bhatt DL; Kochar A
Am Heart J; 2021 Feb; 232():105-115. PubMed ID: 33121978
[TBL] [Abstract][Full Text] [Related]
46. Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses.
Danjuma MI; Sayed R; Aboughalia M; Hassona A; Elsayed BS; Elshafei M; Elzouki A
Heliyon; 2023 Oct; 9(10):e20155. PubMed ID: 37767472
[TBL] [Abstract][Full Text] [Related]
47. Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
Moonla C; Sosothikul D; Chiasakul T; Rojnuckarin P; Uaprasert N
Clin Appl Thromb Hemost; 2021; 27():10760296211008999. PubMed ID: 33874753
[TBL] [Abstract][Full Text] [Related]
48. Remdesivir for the treatment of COVID-19.
Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
[TBL] [Abstract][Full Text] [Related]
49. Anticoagulation outcomes in hospitalized Covid-19 patients: A systematic review and meta-analysis of case-control and cohort studies.
Kamel AM; Sobhy M; Magdy N; Sabry N; Farid S
Rev Med Virol; 2021 May; 31(3):e2180. PubMed ID: 33022834
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis.
Tleyjeh IM; Kashour Z; Damlaj M; Riaz M; Tlayjeh H; Altannir M; Altannir Y; Al-Tannir M; Tleyjeh R; Hassett L; Kashour T
Clin Microbiol Infect; 2021 Feb; 27(2):215-227. PubMed ID: 33161150
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis.
Xiang Z; Yang J; Yang J; Zhang J; Fan Z; Yang C; Di L; Ma C; Wu J; Huang Y
Intern Emerg Med; 2021 Mar; 16(2):487-496. PubMed ID: 33400158
[TBL] [Abstract][Full Text] [Related]
52. Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine.
Oztas M; Bektas M; Karacan I; Aliyeva N; Dag A; Aghamuradov S; Cevirgen SB; Sari S; Bolayirli M; Can G; Hatemi G; Seyahi E; Ozdogan H; Gul A; Ugurlu S
J Med Virol; 2022 Jul; 94(7):3431-3437. PubMed ID: 35315100
[TBL] [Abstract][Full Text] [Related]
53. Comparison of Associations Between Glucocorticoids Treatment and Mortality in COVID-19 Patients and SARS Patients: A Systematic Review and Meta-Analysis.
Li J; Liao X; Zhou Y; Wang L; Yang H; Zhang W; Zhang Z; Kang Y
Shock; 2021 Aug; 56(2):215-228. PubMed ID: 33555845
[TBL] [Abstract][Full Text] [Related]
54. Systemic corticosteroids for the treatment of COVID-19.
Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
[TBL] [Abstract][Full Text] [Related]
55. Vitamin D supplementation, COVID-19 and disease severity: a meta-analysis.
Shah K; Saxena D; Mavalankar D
QJM; 2021 May; 114(3):175-181. PubMed ID: 33486522
[TBL] [Abstract][Full Text] [Related]
56. Colchicine anti-inflammatory therapy for non-intensive care unit hospitalized COVID-19 patients: results from a pilot open-label, randomized controlled clinical trial.
Haroon MZ; Farooq U; Ashraf S; Zeb S; Gillani SY; Malik S; Ali R; Irshad R; Mehmood Z; Abbas Y; Masood A; Ghafoor A; Khalil AT; Asif H; Khan S; Ujjan ID; Nigar R; Livingstone S; Pascual-Figal DA; Togni S; Allergini P; Riva A; Khan A
J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36302537
[TBL] [Abstract][Full Text] [Related]
57. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
Axfors C; Schmitt AM; Janiaud P; Van't Hooft J; Abd-Elsalam S; Abdo EF; Abella BS; Akram J; Amaravadi RK; Angus DC; Arabi YM; Azhar S; Baden LR; Baker AW; Belkhir L; Benfield T; Berrevoets MAH; Chen CP; Chen TC; Cheng SH; Cheng CY; Chung WS; Cohen YZ; Cowan LN; Dalgard O; de Almeida E Val FF; de Lacerda MVG; de Melo GC; Derde L; Dubee V; Elfakir A; Gordon AC; Hernandez-Cardenas CM; Hills T; Hoepelman AIM; Huang YW; Igau B; Jin R; Jurado-Camacho F; Khan KS; Kremsner PG; Kreuels B; Kuo CY; Le T; Lin YC; Lin WP; Lin TH; Lyngbakken MN; McArthur C; McVerry BJ; Meza-Meneses P; Monteiro WM; Morpeth SC; Mourad A; Mulligan MJ; Murthy S; Naggie S; Narayanasamy S; Nichol A; Novack LA; O'Brien SM; Okeke NL; Perez L; Perez-Padilla R; Perrin L; Remigio-Luna A; Rivera-Martinez NE; Rockhold FW; Rodriguez-Llamazares S; Rolfe R; Rosa R; Røsjø H; Sampaio VS; Seto TB; Shahzad M; Soliman S; Stout JE; Thirion-Romero I; Troxel AB; Tseng TY; Turner NA; Ulrich RJ; Walsh SR; Webb SA; Weehuizen JM; Velinova M; Wong HL; Wrenn R; Zampieri FG; Zhong W; Moher D; Goodman SN; Ioannidis JPA; Hemkens LG
Nat Commun; 2021 Apr; 12(1):2349. PubMed ID: 33859192
[TBL] [Abstract][Full Text] [Related]
58. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
59. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.
Dessie ZG; Zewotir T
BMC Infect Dis; 2021 Aug; 21(1):855. PubMed ID: 34418980
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update.
Tleyjeh IM; Kashour Z; Riaz M; Hassett L; Veiga VC; Kashour T
Clin Microbiol Infect; 2021 Aug; 27(8):1076-1082. PubMed ID: 33915284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
